Professional and Reliable IHC Raw Antibody Solutions for Multiple Myeloma
Multiple myeloma involves clonal plasma cell proliferation and alterations in the bone marrow microenvironment. AREX provides high-quality IHC raw antibodies supporting plasma cell phenotype identification and related marker detection to aid in the development of diagnostic, staging, and therapy-related solutions for multiple myeloma.
Core Advantages:
High specificity and low background suited to the plasma cell staining environment of bone marrow tissue
Good sensitivity meeting needs for low-abundance plasma cells in bone marrow samples
Excellent batch-to-batch consistency for large-scale OEM supply
AREX multiple myeloma pathology raw antibodies integrate seamlessly with our
ARExVisual® micropolymer detection system and
Ancillaries supporting reagents to deliver a complete IHC solution.
Contact us to request catalogs, sample testing, or technical consultation.
Product List
